675 related articles for article (PubMed ID: 35906780)
1. Short-chain fatty acids affect the development of inflammatory bowel disease through intestinal barrier, immunology, and microbiota: A promising therapy?
Peng K; Xia S; Xiao S; Yu Q
J Gastroenterol Hepatol; 2022 Sep; 37(9):1710-1718. PubMed ID: 35906780
[TBL] [Abstract][Full Text] [Related]
2. Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases.
Parada Venegas D; De la Fuente MK; Landskron G; González MJ; Quera R; Dijkstra G; Harmsen HJM; Faber KN; Hermoso MA
Front Immunol; 2019; 10():277. PubMed ID: 30915065
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory bowel disease is associated with increased gut-to-blood penetration of short-chain fatty acids: A new, non-invasive marker of a functional intestinal lesion.
Jaworska K; Konop M; Bielinska K; Hutsch T; Dziekiewicz M; Banaszkiewicz A; Ufnal M
Exp Physiol; 2019 Aug; 104(8):1226-1236. PubMed ID: 31243807
[TBL] [Abstract][Full Text] [Related]
4. Human umbilical cord mesenchymal stem cells ameliorate colon inflammation via modulation of gut microbiota-SCFAs-immune axis.
Liu A; Liang X; Wang W; Wang C; Song J; Guo J; Sun D; Wang D; Song M; Qian J; Zhang X
Stem Cell Res Ther; 2023 Sep; 14(1):271. PubMed ID: 37749611
[TBL] [Abstract][Full Text] [Related]
5. Roles of Short-Chain Fatty Acids in Inflammatory Bowel Disease.
Shin Y; Han S; Kwon J; Ju S; Choi TG; Kang I; Kim SS
Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892541
[TBL] [Abstract][Full Text] [Related]
6. Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation.
Gasaly N; de Vos P; Hermoso MA
Front Immunol; 2021; 12():658354. PubMed ID: 34122415
[TBL] [Abstract][Full Text] [Related]
7. A bridge for short-chain fatty acids to affect inflammatory bowel disease, type 1 diabetes, and non-alcoholic fatty liver disease positively: by changing gut barrier.
Liu W; Luo X; Tang J; Mo Q; Zhong H; Zhang H; Feng F
Eur J Nutr; 2021 Aug; 60(5):2317-2330. PubMed ID: 33180143
[TBL] [Abstract][Full Text] [Related]
8. Short chain fatty acids and its producing organisms: An overlooked therapy for IBD?
Deleu S; Machiels K; Raes J; Verbeke K; Vermeire S
EBioMedicine; 2021 Apr; 66():103293. PubMed ID: 33813134
[TBL] [Abstract][Full Text] [Related]
9. The Therapeutic Role of Short-Chain Fatty Acids Mediated Very Low-Calorie Ketogenic Diet-Gut Microbiota Relationships in Paediatric Inflammatory Bowel Diseases.
Alsharairi NA
Nutrients; 2022 Oct; 14(19):. PubMed ID: 36235765
[TBL] [Abstract][Full Text] [Related]
10. A Cross-Talk Between Microbiota-Derived Short-Chain Fatty Acids and the Host Mucosal Immune System Regulates Intestinal Homeostasis and Inflammatory Bowel Disease.
Gonçalves P; Araújo JR; Di Santo JP
Inflamm Bowel Dis; 2018 Feb; 24(3):558-572. PubMed ID: 29462379
[TBL] [Abstract][Full Text] [Related]
11. Dietary fructose-induced gut dysbiosis promotes mouse hippocampal neuroinflammation: a benefit of short-chain fatty acids.
Li JM; Yu R; Zhang LP; Wen SY; Wang SJ; Zhang XY; Xu Q; Kong LD
Microbiome; 2019 Jun; 7(1):98. PubMed ID: 31255176
[TBL] [Abstract][Full Text] [Related]
12. Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations.
van de Wouw M; Boehme M; Lyte JM; Wiley N; Strain C; O'Sullivan O; Clarke G; Stanton C; Dinan TG; Cryan JF
J Physiol; 2018 Oct; 596(20):4923-4944. PubMed ID: 30066368
[TBL] [Abstract][Full Text] [Related]
13. Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases.
Ashique S; De Rubis G; Sirohi E; Mishra N; Rihan M; Garg A; Reyes RJ; Manandhar B; Bhatt S; Jha NK; Singh TG; Gupta G; Singh SK; Chellappan DK; Paudel KR; Hansbro PM; Oliver BG; Dua K
Chem Biol Interact; 2022 Dec; 368():110231. PubMed ID: 36288778
[TBL] [Abstract][Full Text] [Related]
14. Short chain fatty acids: Microbial metabolites for gut-brain axis signalling.
O'Riordan KJ; Collins MK; Moloney GM; Knox EG; Aburto MR; Fülling C; Morley SJ; Clarke G; Schellekens H; Cryan JF
Mol Cell Endocrinol; 2022 Apr; 546():111572. PubMed ID: 35066114
[TBL] [Abstract][Full Text] [Related]
15. Gut-Liver Physiomimetics Reveal Paradoxical Modulation of IBD-Related Inflammation by Short-Chain Fatty Acids.
Trapecar M; Communal C; Velazquez J; Maass CA; Huang YJ; Schneider K; Wright CW; Butty V; Eng G; Yilmaz O; Trumper D; Griffith LG
Cell Syst; 2020 Mar; 10(3):223-239.e9. PubMed ID: 32191873
[TBL] [Abstract][Full Text] [Related]
16. Puerarin improves the bone micro-environment to inhibit OVX-induced osteoporosis via modulating SCFAs released by the gut microbiota and repairing intestinal mucosal integrity.
Li B; Liu M; Wang Y; Gong S; Yao W; Li W; Gao H; Wei M
Biomed Pharmacother; 2020 Dec; 132():110923. PubMed ID: 33125971
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of short-chain fatty acid production by gut microbiota in neurodegenerative disorders.
Yadav S; Dwivedi A; Tripathi A; Tripathi AK
Nutr Res; 2022 Oct; 106():72-84. PubMed ID: 36152586
[TBL] [Abstract][Full Text] [Related]
18. Alterations in fecal short chain fatty acids (SCFAs) and branched short-chain fatty acids (BCFAs) in men with benign prostatic hyperplasia (BPH) and metabolic syndrome (MetS).
Ratajczak W; Mizerski A; Rył A; Słojewski M; Sipak O; Piasecka M; Laszczyńska M
Aging (Albany NY); 2021 Apr; 13(8):10934-10954. PubMed ID: 33847600
[TBL] [Abstract][Full Text] [Related]
19. Short Chain Fatty Acids: Essential Weapons of Traditional Medicine in Treating Inflammatory Bowel Disease.
Yao Y; Liu Y; Xu Q; Mao L
Molecules; 2024 Jan; 29(2):. PubMed ID: 38257292
[TBL] [Abstract][Full Text] [Related]
20. Regulatory role of short-chain fatty acids in inflammatory bowel disease.
Zhang Z; Zhang H; Chen T; Shi L; Wang D; Tang D
Cell Commun Signal; 2022 May; 20(1):64. PubMed ID: 35546404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
